Is ELDN stock safe? | Glauxie AI

Q: Is ELDN stock safe?

Eledon Pharmaceuticals, Inc. (ELDN) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO David-Alexandre C. Gros. Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and... Employees: 33.

Q: What are the risks of investing in ELDN?

Identify key risks of investing in ELDN — debt, competition, volatility, and sector headwinds.

Q: Is ELDN a good long-term investment?

Evaluate ELDN as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does ELDN have?

Review ELDN total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is ELDN stock safe?

🦉

Eledon Pharmaceuticals, Inc. (ELDN)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEODavid-Alexandre C. Gros

Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized...

Key Executives

Name	Title
Bryan E. Smith	General Counsel, Corporate Secretary & Chief Compliance Officer
David Hovland	Chief Regulatory Officer
David-Alexandre C. Gros	Chief Executive Officer & Non Independent Director
Eliezer Katz	Chief Medical Officer
John Herberger	Vice President of Technical Operations
Marina Escudero	Vice President & Head of Clinical Operations

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

ELDN Profile Financials

What are the risks of investing in ELDN? Is ELDN a good long-term investment? How much debt does ELDN have?